Results 31 to 40 of about 4,730,641 (404)
Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial. [PDF]
, 2015 BackgroundTiotropium is an anticholinergic bronchodilator for symptom relief and reducing exacerbations with an established safety profile in patients with chronic obstructive pulmonary disease (COPD).
Decramer, Marc +3 more
core +1 more source
Cardiac rehabilitation for heart failure: Do older people want to attend and are they referred? [PDF]
, 2014 Purpose Uptake of cardiac rehabilitation services by older people is suboptimal. Offering suitable services may increase participation. This study investigated older heart failure patients' preferences between hospital, community and home-based service ...
Balady +30 more
core +2 more sources
Cardiac Failure and Benzodiazepines [PDF]
Sleep, 1993 Nine patients with stable cardiac failure and mean left ventricular ejection fraction of 30% were investigated. All had previously been prescribed a benzodiazepine hypnotic by their home physicians, but the medication had been discontinued for at least 1 month.
Riccardo Stoohs +4 more
openaire +3 more sources
COPD and cardiovascular disease [PDF]
, 2019 COPD is one of the major public health problems in people aged 40 years or above. It is currently the 4th leading cause of death in the world and projected to be the 3rd leading cause of death by 2020.
André, S. +5 more
core +3 more sources
New England Journal of Medicine, 2004 BACKGROUND We tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death and hospitalization among patients with ...
M. Bristow +11 more
semanticscholar +1 more source
Myocardial fibrosis in stroke survivors [PDF]
, 2015 Stroke survivors are most likely to die of cardiac death, yet few undergo comprehensive cardiac assessment to look for reversible causes. Myocardial fibrosis (MF) is not only the hallmark of cardiomyopathy, but also a substrate for sudden cardiac death ...
Allgar, V. +6 more
core +1 more source
Fabry Disease Cardiomyopathy: A Review of the Role of Cardiac Imaging from Diagnosis to Treatment
Reviews in Cardiovascular Medicine, 2022 Fabry disease is a rare X-linked inherited lysosomal storage disorder caused by the absence or reduction of alfa-galactosidase A activity in lysosomes, resulting in accumulation of glycosphingolipids in various tissues.
Laura Fuertes Kenneally +4 more
doaj +1 more source
Cardiac hypertrophy and heart failure: from the case to review of literature [PDF]
, 2016 In response to an increased workload due to physiological or pathological stimuli, the heart may undergo a process of growth with increased muscle mass called cardiac hypertrophy. It is a particular mechanism of long term compensation used by the heart
Massoni, Francesco +4 more
core +1 more source
Multidisciplinary Cardiac Rehabilitation and Long-Term Prognosis in Patients With Heart Failure
Circulation: Heart Failure, 2020 Supplemental Digital Content is available in the text. Background: Exercise-based cardiac rehabilitation (CR) improves health-related quality of life and exercise capacity in patients with heart failure (HF).
K. Kamiya +11 more
semanticscholar +1 more source
Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach
npj Systems Biology and Applications, 2017 Cardiology: Heart Failure Medication Reduces Heart Size The new wonder drug in heart failure management, Sacubitril/Valsartan, rejuvenates the heart by preventing its dilation. Using data from myocardial infarction and heart failure samples, we generated
Oriol Iborra-Egea +6 more
doaj +1 more source